Jane Street’s Agilon Health AGL Stock Holding History

Jane Street’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-440	Closed	-$7.58K	–	11441
2025 Q4	$7.58K	Buy	+440	New	+$8.53K	﹤0.01%	10877
2025 Q1	–	Sell	-10,692	Closed	-$508K	–	9314
2024 Q4	$508K	Buy	10,692 +7,912	+285%	+$478K	﹤0.01%	6748
2024 Q3	$273K	Sell	2,780 -804	-22%	-$104K	﹤0.01%	8184
2024 Q2	$586K	Buy	3,584 +1,584	+79%	+$226K	﹤0.01%	6748
2024 Q1	$305K	Sell	2,000 -10,380	-84%	-$1.73M	﹤0.01%	7536
2023 Q4	$3.88M	Sell	12,380 -2,608	-17%	-$944K	﹤0.01%	3231
2023 Q3	$6.65M	Buy	14,988 +444	+3%	+$201K	﹤0.01%	2241
2023 Q2	$6.3M	Sell	14,544 -476	-3%	-$268K	﹤0.01%	2441
2023 Q1	$8.92M	Buy	15,020 +14,072	+1,484%	+$7.88M	﹤0.01%	1762
2022 Q4	$383K	Sell	948 -8,336	-90%	-$3.91M	﹤0.01%	6607
2022 Q3	$5.43M	Sell	9,284 -2,504	-21%	-$1.5M	﹤0.01%	2479
2022 Q2	$6.43M	Buy	11,788 +8,632	+274%	+$4.37M	﹤0.01%	2302
2022 Q1	$2M	Sell	3,156 -692	-18%	-$357K	﹤0.01%	4751
2021 Q4	$2.6M	Sell	3,848 -396	-9%	-$241K	﹤0.01%	3963
2021 Q3	$2.78M	Buy	4,244 +396	+10%	+$338K	﹤0.01%	3812
2021 Q2	$3.9M	Buy	+3,848	New	+$3.37M	﹤0.01%	3075

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Jane Street's AGL Position: Q1 2026 in Review

Jane Street increased its Agilon Health (AGL) stake by 1,678% in Q1 2026, buying an estimated $231K and bringing the position to 15,113 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #10535.

Jane Street first reported a position in AGL in Q3 2021 and has held it in 17 quarters since. The position peaked at $9.53M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Jane Street held 15,113 shares of Agilon Health worth $120K as of Q1 2026.
Jane Street bought 14,263 Agilon Health shares in Q1 2026, an estimated $231K.
Agilon Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10535 holding.
Jane Street first reported a position in Agilon Health in Q3 2021 and has held it in 17 quarters since.
Jane Street's Agilon Health position peaked at $9.53M in Q1 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.